| 30/0358/18-S |
9584C |
Agomelatín Stada |
tbl flm 100x25 mg (blis.OPA/Al/PVC/Al) |
STD |
29.10.2023 |
| 30/0358/18-S |
9583C |
Agomelatín Stada |
tbl flm 98x25 mg (blis.OPA/Al/PVC/Al) |
STD |
29.10.2023 |
| 30/0358/18-S |
9582C |
Agomelatín Stada |
tbl flm 84x25 mg (blis.OPA/Al/PVC/Al) |
STD |
29.10.2023 |
| 30/0358/18-S |
9581C |
Agomelatín Stada |
tbl flm 56x25 mg (blis.OPA/Al/PVC/Al) |
STD |
29.10.2023 |
| 30/0358/18-S |
9580C |
Agomelatín Stada |
tbl flm 42x25 mg (blis.OPA/Al/PVC/Al) |
STD |
29.10.2023 |
| 30/0358/18-S |
9579C |
Agomelatín Stada |
tbl flm 28x25 mg (blis.OPA/Al/PVC/Al) |
STD |
29.10.2023 |
| 30/0358/18-S |
9578C |
Agomelatín Stada |
tbl flm 14x25 mg (blis.OPA/Al/PVC/Al) |
STD |
29.10.2023 |
| 30/0358/18-S |
9576C |
Agomelatín Stada |
tbl flm 7x25 mg (blis.OPA/Al/PVC/Al) |
STD |
29.10.2023 |
| 44/0250/18-S |
8527C |
EVEROLIMUS STADA 10 mg |
tbl 90x10 mg (blis.OPA/Al/PVC/Al) |
STD |
14.08.2023 |
| 44/0250/18-S |
8526C |
EVEROLIMUS STADA 10 mg |
tbl 30x10 mg (blis.OPA/Al/PVC/Al) |
STD |
14.08.2023 |
| 44/0250/18-S |
8525C |
EVEROLIMUS STADA 10 mg |
tbl 10x10 mg (blis.OPA/Al/PVC/Al) |
STD |
14.08.2023 |
| 44/0249/18-S |
8524C |
EVEROLIMUS STADA 5 mg |
tbl 90x5 mg (blis.OPA/Al/PVC/Al) |
STD |
14.08.2023 |
| 44/0249/18-S |
8523C |
EVEROLIMUS STADA 5 mg |
tbl 30x5 mg (blis.OPA/Al/PVC/Al) |
STD |
14.08.2023 |
| 44/0249/18-S |
8522C |
EVEROLIMUS STADA 5 mg |
tbl 10x5 mg (blis.OPA/Al/PVC/Al) |
STD |
14.08.2023 |
| 44/0248/18-S |
8521C |
EVEROLIMUS STADA 2,5 mg |
tbl 90x2,5 mg (blis.OPA/Al/PVC/Al) |
STD |
14.08.2023 |
| 44/0248/18-S |
8520C |
EVEROLIMUS STADA 2,5 mg |
tbl 30x2,5 mg (blis.OPA/Al/PVC/Al) |
STD |
14.08.2023 |
| 44/0248/18-S |
8519C |
EVEROLIMUS STADA 2,5 mg |
tbl 10x2,5 mg (blis.OPA/Al/PVC/Al) |
STD |
14.08.2023 |
| 07/0201/18-S |
8272C |
Ibugripp Forte 400 mg/10 mg filmom obalené tablety |
tbl flm 24x400 mg/10 mg (blis.PVC/PE/PVDC/Al) |
STD |
14.06.2023 |
| 07/0201/18-S |
8271C |
Ibugripp Forte 400 mg/10 mg filmom obalené tablety |
tbl flm 20x400 mg/10 mg (blis.PVC/PE/PVDC/Al) |
STD |
14.06.2023 |
| 07/0201/18-S |
8270C |
Ibugripp Forte 400 mg/10 mg filmom obalené tablety |
tbl flm 16x400 mg/10 mg (blis.PVC/PE/PVDC/Al) |
STD |
14.06.2023 |
| 07/0201/18-S |
8269C |
Ibugripp Forte 400 mg/10 mg filmom obalené tablety |
tbl flm 12x400 mg/10 mg (blis.PVC/PE/PVDC/Al) |
STD |
14.06.2023 |
| 07/0201/18-S |
8268C |
Ibugripp Forte 400 mg/10 mg filmom obalené tablety |
tbl flm 10x400 mg/10 mg (blis.PVC/PE/PVDC/Al) |
STD |
14.06.2023 |
| 44/0163/18-S |
7936C |
Bortezomib STADA |
sol inj 1x3,5 mg/1,4 ml (liek.inj.skl.) |
STD |
22.05.2023 |
| 87/0340/17-S |
5841C |
Kyselina zoledrónová STADA 5 mg/100 ml infúzny roztok |
sol inf 5x100 ml/5 mg (liek.inj.skl.) |
STD |
20.11.2022 |
| 87/0340/17-S |
5840C |
Kyselina zoledrónová STADA 5 mg/100 ml infúzny roztok |
sol inf 4x100 ml/5 mg (liek.inj.skl.) |
STD |
20.11.2022 |
| 87/0340/17-S |
5839C |
Kyselina zoledrónová STADA 5 mg/100 ml infúzny roztok |
sol inf 1x100 ml/5 mg (liek.inj.skl.) |
STD |
20.11.2022 |
| 07/0253/17-S |
5002C |
Grippostad horúci nápoj |
plo por 10x600 mg (vre.PAP/Al/LDPE) |
STD |
24.08.2022 |
| 07/0253/17-S |
5001C |
Grippostad horúci nápoj |
plo por 5x600 mg (vre.PAP/Al/LDPE) |
STD |
24.08.2022 |
| 58/0248/17-S |
4967C |
Olmestad 40 mg/10 mg |
tbl flm 112x40 mg/10 mg (blis.OPA/Al/PVC/Al) |
STD |
21.08.2022 |
| 58/0248/17-S |
4966C |
Olmestad 40 mg/10 mg |
tbl flm 100x40 mg/10 mg (blis.OPA/Al/PVC/Al) |
STD |
21.08.2022 |
| 58/0248/17-S |
4965C |
Olmestad 40 mg/10 mg |
tbl flm 98x40 mg/10 mg (blis.OPA/Al/PVC/Al) |
STD |
21.08.2022 |
| 58/0248/17-S |
4964C |
Olmestad 40 mg/10 mg |
tbl flm 90x40 mg/10 mg (blis.OPA/Al/PVC/Al) |
STD |
21.08.2022 |
| 58/0248/17-S |
4963C |
Olmestad 40 mg/10 mg |
tbl flm 60x40 mg/10 mg (blis.OPA/Al/PVC/Al) |
STD |
21.08.2022 |
| 58/0248/17-S |
4962C |
Olmestad 40 mg/10 mg |
tbl flm 56x40 mg/10 mg (blis.OPA/Al/PVC/Al) |
STD |
21.08.2022 |
| 58/0248/17-S |
4961C |
Olmestad 40 mg/10 mg |
tbl flm 30x40 mg/10 mg (blis.OPA/Al/PVC/Al) |
STD |
21.08.2022 |
| 58/0248/17-S |
4960C |
Olmestad 40 mg/10 mg |
tbl flm 28x40 mg/10 mg (blis.OPA/Al/PVC/Al) |
STD |
21.08.2022 |
| 58/0248/17-S |
4959C |
Olmestad 40 mg/10 mg |
tbl flm 14x40 mg/10 mg (blis.OPA/Al/PVC/Al) |
STD |
21.08.2022 |
| 58/0248/17-S |
4958C |
Olmestad 40 mg/10 mg |
tbl flm 10x40 mg/10 mg (blis.OPA/Al/PVC/Al) |
STD |
21.08.2022 |
| 58/0247/17-S |
4957C |
Olmestad 40 mg/5 mg |
tbl flm 112x40 mg/5 mg (blis.OPA/Al/PVC/Al) |
STD |
21.08.2022 |
| 58/0247/17-S |
4956C |
Olmestad 40 mg/5 mg |
tbl flm 100x40 mg/5 mg (blis.OPA/Al/PVC/Al) |
STD |
21.08.2022 |
| 58/0247/17-S |
4955C |
Olmestad 40 mg/5 mg |
tbl flm 98x40 mg/5 mg (blis.OPA/Al/PVC/Al) |
STD |
21.08.2022 |
| 58/0247/17-S |
4954C |
Olmestad 40 mg/5 mg |
tbl flm 90x40 mg/5 mg (blis.OPA/Al/PVC/Al) |
STD |
21.08.2022 |
| 58/0247/17-S |
4953C |
Olmestad 40 mg/5 mg |
tbl flm 60x40 mg/5 mg (blis.OPA/Al/PVC/Al) |
STD |
21.08.2022 |
| 58/0247/17-S |
4952C |
Olmestad 40 mg/5 mg |
tbl flm 56x40 mg/5 mg (blis.OPA/Al/PVC/Al) |
STD |
21.08.2022 |
| 58/0247/17-S |
4951C |
Olmestad 40 mg/5 mg |
tbl flm 30x40 mg/5 mg (blis.OPA/Al/PVC/Al) |
STD |
21.08.2022 |
| 58/0247/17-S |
4950C |
Olmestad 40 mg/5 mg |
tbl flm 28x40 mg/5 mg (blis.OPA/Al/PVC/Al) |
STD |
21.08.2022 |
| 58/0247/17-S |
4949C |
Olmestad 40 mg/5 mg |
tbl flm 14x40 mg/5 mg (blis.OPA/Al/PVC/Al) |
STD |
21.08.2022 |
| 58/0247/17-S |
4948C |
Olmestad 40 mg/5 mg |
tbl flm 10x40 mg/5 mg (blis.OPA/Al/PVC/Al) |
STD |
21.08.2022 |
| 58/0246/17-S |
4947C |
Olmestad 20 mg/5 mg |
tbl flm 112x20 mg/5 mg (blis.OPA/Al/PVC/Al) |
STD |
21.08.2022 |
| 58/0246/17-S |
4946C |
Olmestad 20 mg/5 mg |
tbl flm 100x20 mg/5 mg (blis.OPA/Al/PVC/Al) |
STD |
21.08.2022 |
1
